{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T07:11:11Z","timestamp":1794726671499,"version":"4.9.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"DOI":"10.1186\/s13018-025-05804-1","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T04:43:49Z","timestamp":1746247429000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Obacunone acts as a histone deacetylase 1 inhibitor to limit p38MAPK signaling and alleviate osteoarthritis progression"],"prefix":"10.1186","volume":"20","author":[{"given":"Yong","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Qian","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,3]]},"reference":[{"issue":"2","key":"5804_CR1","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/BOR.0000000000000985","volume":"36","author":"MCC Minnig","year":"2024","unstructured":"Minnig MCC, Golightly YM, Nelson AE. Epidemiology of osteoarthritis: literature update 2022\u20132023. Curr Opin Rheumatol. 2024;36(2):108\u201312.","journal-title":"Curr Opin Rheumatol"},{"key":"5804_CR2","unstructured":"GBD 2021 Gout Collaborators. Global, regional, and national burden of gout, 1990\u20132020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2024;6(8):e507-e517."},{"issue":"2","key":"5804_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cger.2021.11.005","volume":"38","author":"GA Hawker","year":"2022","unstructured":"Hawker GA, King LK. The burden of osteoarthritis in older adults. Clin Geriatr Med. 2022;38(2):181\u201392.","journal-title":"Clin Geriatr Med"},{"issue":"1","key":"5804_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41392-023-01330-w","volume":"8","author":"Q Yao","year":"2023","unstructured":"Yao Q, Wu X, Tao C, Gong W, Chen M, Qu M, Zhong Y, He T, Chen S, Xiao G. Osteoarthritis: pathogenic signaling pathways and therapeutic targets. Signal Transduct Target Ther. 2023;8(1):56.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"5804_CR5","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41584-022-00749-9","volume":"18","author":"E Sanchez-Lopez","year":"2022","unstructured":"Sanchez-Lopez E, Coras R, Torres A, Lane NE, Guma M. Synovial inflammation in osteoarthritis progression. Nat Rev Rheumatol. 2022;18(5):258\u201375.","journal-title":"Nat Rev Rheumatol"},{"issue":"17","key":"5804_CR6","doi-asserted-by":"publisher","first-page":"9208","DOI":"10.3390\/ijms22179208","volume":"22","author":"V Molnar","year":"2021","unstructured":"Molnar V, Mati\u0161i\u0107 V, Kodvanj I, Bjelica R, Jele\u010d \u017d, Hudetz D, Rod E, \u010cukelj F, Vrdoljak T, Vidovi\u0107 D, et al. Cytokines and chemokines involved in osteoarthritis pathogenesis. Int J Mol Sci. 2021;22(17):9208.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5804_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.bbapap.2011.06.020","volume":"1824","author":"L Troeberg","year":"2012","unstructured":"Troeberg L, Nagase H. Proteases involved in cartilage matrix degradation in osteoarthritis. Biochim Biophys Acta. 2012;1824(1):133\u201345.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"5804_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41584-021-00724-w","volume":"18","author":"T Hodgkinson","year":"2022","unstructured":"Hodgkinson T, Kelly DC, Curtin CM, O\u2019Brien FJ. Mechanosignalling in cartilage: an emerging target for the treatment of osteoarthritis. Nat Rev Rheumatol. 2022;18(2):67\u201384.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"5804_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/BOR.0000000000000923","volume":"35","author":"AJ Knights","year":"2023","unstructured":"Knights AJ, Redding SJ, Maerz T. Inflammation in osteoarthritis: the latest progress and ongoing challenges. Curr Opin Rheumatol. 2023;35(2):128\u201334.","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"5804_CR10","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3390\/molecules29081791","volume":"29","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Gu J, Li J, Zhang H, Wang M, Li Y, Wang T, Wang J, Shi R. Obacunone, a promising phytochemical triterpenoid: research progress on its pharmacological activity and mechanism. Molecules. 2024;29(8):1791.","journal-title":"Molecules"},{"key":"5804_CR11","doi-asserted-by":"publisher","first-page":"155912","DOI":"10.1016\/j.phymed.2024.155912","volume":"133","author":"Y Chen","year":"2024","unstructured":"Chen Y, Liu H, Han R, Lin J, Yang J, Guo M, Yang Z, Song L. Analyzing how SiMiao Wan regulates ferroptosis to prevent RA-ILD using metabolomics and cyberpharmacology. Phytomedicine. 2024;133:155912.","journal-title":"Phytomedicine"},{"key":"5804_CR12","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jare.2023.01.003","volume":"53","author":"J He","year":"2023","unstructured":"He J, Zheng L, Li X, Huang F, Hu S, Chen L, Jiang M, Lin X, Jiang H, Zeng Y, et al. Obacunone targets macrophage migration inhibitory factor (MIF) to impede osteoclastogenesis and alleviate ovariectomy-induced bone loss. J Adv Res. 2023;53:235\u201348.","journal-title":"J Adv Res"},{"key":"5804_CR13","doi-asserted-by":"publisher","first-page":"156134","DOI":"10.1016\/j.cyto.2023.156134","volume":"164","author":"H Hu","year":"2023","unstructured":"Hu H, Wang X, Huang Y, He B, Zhu J, Sun K, Deng C, Guo Y, Hao D, Jian B. Obacunone inhibits RANKL\/M-CSF-mediated osteoclastogenesis by suppressing integrin- FAK-Src signaling. Cytokine. 2023;164:156134.","journal-title":"Cytokine"},{"issue":"5","key":"5804_CR14","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.3390\/ijms22052483","volume":"22","author":"KR Park","year":"2021","unstructured":"Park KR, Kim S, Cho M, Yun HM. Limonoid triterpene, obacunone increases runt-related transcription factor 2 to promote osteoblast differentiation and function. Int J Mol Sci. 2021;22(5):2483.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"5804_CR15","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.joca.2005.03.004","volume":"13","author":"S Kamekura","year":"2005","unstructured":"Kamekura S, Hoshi K, Shimoaka T, Chung U, Chikuda H, Yamada T, Uchida M, Ogata N, Seichi A, Nakamura K, et al. Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthritis Cartilage. 2005;13(7):632\u201341.","journal-title":"Osteoarthritis Cartilage"},{"issue":"Suppl 3","key":"5804_CR16","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/j.joca.2010.05.025","volume":"18","author":"SS Glasson","year":"2010","unstructured":"Glasson SS, Chambers MG, Van Den Berg WB, Little CB. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis Cartilage. 2010;18(Suppl 3):S17-23.","journal-title":"Osteoarthritis Cartilage"},{"key":"5804_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.phrs.2017.08.007","volume":"128","author":"NM Khan","year":"2018","unstructured":"Khan NM, Haqqi TM. Epigenetics in osteoarthritis: potential of HDAC inhibitors as therapeutics. Pharmacol Res. 2018;128:73\u20139.","journal-title":"Pharmacol Res"},{"issue":"10","key":"5804_CR18","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1096\/fj.09-133215","volume":"23","author":"S Hong","year":"2009","unstructured":"Hong S, Derfoul A, Pereira-Mouries L, Hall DJ. A novel domain in histone deacetylase 1 and 2 mediates repression of cartilage-specific genes in human chondrocytes. Faseb J. 2009;23(10):3539\u201352.","journal-title":"Faseb J"},{"issue":"2","key":"5804_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.mcna.2019.10.007","volume":"104","author":"B Abramoff","year":"2020","unstructured":"Abramoff B, Caldera FE. Osteoarthritis: pathology, diagnosis, and treatment options. Med Clin North Am. 2020;104(2):293\u2013311.","journal-title":"Med Clin North Am"},{"issue":"12","key":"5804_CR20","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.joca.2004.09.003","volume":"12","author":"K Sugimoto","year":"2004","unstructured":"Sugimoto K, Iizawa T, Harada H, Yamada K, Katsumata M, Takahashi M. Cartilage degradation independent of MMP\/aggrecanases. Osteoarthritis Cartilage. 2004;12(12):1006\u201314.","journal-title":"Osteoarthritis Cartilage"},{"issue":"9","key":"5804_CR21","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1002\/jbmr.3737","volume":"34","author":"SE Catheline","year":"2019","unstructured":"Catheline SE, Hoak D, Chang M, Ketz JP, Hilton MJ, Zuscik MJ, Jonason JH. Chondrocyte-specific RUNX2 overexpression accelerates post-traumatic osteoarthritis progression in adult mice. J Bone Miner Res. 2019;34(9):1676\u201389.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"5804_CR22","first-page":"102","volume":"13","author":"OS Ashruf","year":"2022","unstructured":"Ashruf OS, Ansari MY. Natural compounds: potential therapeutics for the inhibition of cartilage matrix degradation in osteoarthritis. Life (Basel). 2022;13(1):102.","journal-title":"Life (Basel)"},{"key":"5804_CR23","doi-asserted-by":"publisher","first-page":"1759720x2110702","DOI":"10.1177\/1759720X211070205","volume":"14","author":"MN Horcajada","year":"2022","unstructured":"Horcajada MN, Beaumont M, Sauvageot N, Poquet L, Saboundjian M, Costes B, Verdonk P, Brands G, Brasseur J, Urbin-Choffray D, et al. An oleuropein-based dietary supplement may improve joint functional capacity in older people with high knee joint pain: findings from a multicentre-RCT and post hoc analysis. Ther Adv Musculoskelet Dis. 2022;14:1759720x211070205.","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"2","key":"5804_CR24","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.3892\/mmr.2017.6771","volume":"16","author":"J Wang","year":"2017","unstructured":"Wang J, Ma J, Gu JH, Wang FY, Shang XS, Tao HR, Wang X. Regulation of type II collagen, matrix metalloproteinase-13 and cell proliferation by interleukin-1\u03b2 is mediated by curcumin via inhibition of NF-\u03baB signaling in rat chondrocytes. Mol Med Rep. 2017;16(2):1837\u201345.","journal-title":"Mol Med Rep"},{"issue":"1","key":"5804_CR25","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1006\/bbrc.2001.5363","volume":"286","author":"S Sudhakar","year":"2001","unstructured":"Sudhakar S, Katz MS, Elango N. Analysis of type-I and type-II RUNX2 protein expression in osteoblasts. Biochem Biophys Res Commun. 2001;286(1):74\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"5804_CR26","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0092-8674(00)80257-3","volume":"89","author":"P Ducy","year":"1997","unstructured":"Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2\/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997;89(5):747\u201354.","journal-title":"Cell"},{"issue":"1","key":"5804_CR27","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s13046-019-1350-5","volume":"38","author":"G Manzotti","year":"2019","unstructured":"Manzotti G, Torricelli F, Donati B, Sancisi V, Gugnoni M, Ciarrocchi A. HDACs control RUNX2 expression in cancer cells through redundant and cell context-dependent mechanisms. J Exp Clin Cancer Res. 2019;38(1):346.","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"5804_CR28","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1002\/jbmr.4386","volume":"36","author":"X Qin","year":"2021","unstructured":"Qin X, Jiang Q, Komori H, Sakane C, Fukuyama R, Matsuo Y, Ito K, Miyazaki T, Komori T. Runt-related transcription factor-2 (Runx2) is required for bone matrix protein gene expression in committed osteoblasts in mice. J Bone Miner Res. 2021;36(10):2081\u201395.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"5804_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00418-018-1640-6","volume":"149","author":"T Komori","year":"2018","unstructured":"Komori T. Runx2, an inducer of osteoblast and chondrocyte differentiation. Histochem Cell Biol. 2018;149(4):313\u201323.","journal-title":"Histochem Cell Biol"},{"issue":"6","key":"5804_CR30","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41584-019-0221-y","volume":"15","author":"PG Conaghan","year":"2019","unstructured":"Conaghan PG, Cook AD, Hamilton JA, Tak PP. Therapeutic options for targeting inflammatory osteoarthritis pain. Nat Rev Rheumatol. 2019;15(6):355\u201363.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"5804_CR31","doi-asserted-by":"publisher","first-page":"e1780","DOI":"10.1002\/wnan.1780","volume":"14","author":"M Di Francesco","year":"2022","unstructured":"Di Francesco M, Fragassi A, Pannuzzo M, Ferreira M, Brahmachari S, Decuzzi P. Management of osteoarthritis: From drug molecules to nano\/micromedicines. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022;14(3):e1780.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"5804_CR32","doi-asserted-by":"publisher","first-page":"101249","DOI":"10.1016\/j.arr.2020.101249","volume":"66","author":"L Zheng","year":"2021","unstructured":"Zheng L, Zhang Z, Sheng P, Mobasheri A. The role of metabolism in chondrocyte dysfunction and the progression of osteoarthritis. Ageing Res Rev. 2021;66:101249.","journal-title":"Ageing Res Rev"},{"key":"5804_CR33","doi-asserted-by":"publisher","first-page":"110452","DOI":"10.1016\/j.biopha.2020.110452","volume":"129","author":"MY Ansari","year":"2020","unstructured":"Ansari MY, Ahmad N, Haqqi TM. Oxidative stress and inflammation in osteoarthritis pathogenesis: role of polyphenols. Biomed Pharmacother. 2020;129:110452.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"5804_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41419-020-03341-9","volume":"12","author":"Q Guo","year":"2021","unstructured":"Guo Q, Chen X, Chen J, Zheng G, Xie C, Wu H, Miao Z, Lin Y, Wang X, Gao W, et al. STING promotes senescence, apoptosis, and extracellular matrix degradation in osteoarthritis via the NF-\u03baB signaling pathway. Cell Death Dis. 2021;12(1):13.","journal-title":"Cell Death Dis"},{"issue":"6","key":"5804_CR35","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1517\/14728222.7.6.701","volume":"7","author":"K Matsui","year":"2003","unstructured":"Matsui K, Tsutsui H, Nakanishi K. Pathophysiological roles for IL-18 in inflammatory arthritis. Expert Opin Ther Targets. 2003;7(6):701\u201324.","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"5804_CR36","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1080\/13880209.2020.1812673","volume":"58","author":"X Luo","year":"2020","unstructured":"Luo X, Yu Z, Yue B, Ren J, Zhang J, Mani S, Wang Z, Dou W. Obacunone reduces inflammatory signalling and tumour occurrence in mice with chronic inflammation-induced colorectal cancer. Pharm Biol. 2020;58(1):886\u201397.","journal-title":"Pharm Biol"},{"issue":"6","key":"5804_CR37","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1002\/biof.1987","volume":"49","author":"Y Han","year":"2023","unstructured":"Han Y, Luo L, Li H, Zhang L, Yan Y, Fang M, Yu J, Gao X, Liu Y, Huang C, et al. Nomilin and its analogue obacunone alleviate NASH and hepatic fibrosis in mice via enhancing antioxidant and anti-inflammation capacity. BioFactors. 2023;49(6):1189\u2013204.","journal-title":"BioFactors"},{"key":"5804_CR38","doi-asserted-by":"publisher","first-page":"154469","DOI":"10.1016\/j.phymed.2022.154469","volume":"107","author":"Y Chen","year":"2022","unstructured":"Chen Y, Peng M, Li W, Zhao M, Cao X, Li C, Zhang H, Yang M, Liang L, Yue Y, et al. Inhibition of inflammasome activation via sphingolipid pathway in acute lung injury by Huanglian Jiedu decoction: an integrative pharmacology approach. Phytomedicine. 2022;107:154469.","journal-title":"Phytomedicine"},{"key":"5804_CR39","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3389\/fmicb.2020.00497","volume":"11","author":"X Luo","year":"2020","unstructured":"Luo X, Yue B, Yu Z, Ren Y, Zhang J, Ren J, Wang Z, Dou W. Obacunone protects against ulcerative colitis in mice by modulating gut microbiota, attenuating TLR4\/NF-\u03baB signaling cascades, and improving disrupted epithelial barriers. Front Microbiol. 2020;11:497.","journal-title":"Front Microbiol"},{"key":"5804_CR40","doi-asserted-by":"publisher","first-page":"101312","DOI":"10.1016\/j.tranon.2021.101312","volume":"16","author":"G Shanmugam","year":"2022","unstructured":"Shanmugam G, Rakshit S, Sarkar K. HDAC inhibitors: targets for tumor therapy, immune modulation and lung diseases. Transl Oncol. 2022;16:101312.","journal-title":"Transl Oncol"},{"key":"5804_CR41","doi-asserted-by":"publisher","first-page":"560117","DOI":"10.3389\/fcell.2020.560117","volume":"8","author":"H Zhang","year":"2020","unstructured":"Zhang H, Ji L, Yang Y, Zhang X, Gang Y, Bai L. The role of HDACs and HDACi in cartilage and osteoarthritis. Front Cell Dev Biol. 2020;8:560117.","journal-title":"Front Cell Dev Biol"},{"issue":"8","key":"5804_CR42","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11926-016-0602-z","volume":"18","author":"LR Carpio","year":"2016","unstructured":"Carpio LR, Westendorf JJ. Histone deacetylases in cartilage homeostasis and osteoarthritis. Curr Rheumatol Rep. 2016;18(8):52.","journal-title":"Curr Rheumatol Rep"},{"issue":"8","key":"5804_CR43","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1007\/s11033-010-0055-9","volume":"37","author":"WP Chen","year":"2010","unstructured":"Chen WP, Bao JP, Hu PF, Feng J, Wu LD. Alleviation of osteoarthritis by Trichostatin A, a histone deacetylase inhibitor, in experimental osteoarthritis. Mol Biol Rep. 2010;37(8):3967\u201372.","journal-title":"Mol Biol Rep"},{"issue":"2","key":"5804_CR44","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.intimp.2013.06.027","volume":"17","author":"HM Zhong","year":"2013","unstructured":"Zhong HM, Ding QH, Chen WP, Luo RB. Vorinostat, a HDAC inhibitor, showed anti-osteoarthritic activities through inhibition of iNOS and MMP expression, p38 and ERK phosphorylation and blocking NF-\u03baB nuclear translocation. Int Immunopharmacol. 2013;17(2):329\u201335.","journal-title":"Int Immunopharmacol"},{"key":"5804_CR45","doi-asserted-by":"publisher","first-page":"723","DOI":"10.2147\/JIR.S348491","volume":"15","author":"Z Li","year":"2022","unstructured":"Li Z, Dai A, Yang M, Chen S, Deng Z, Li L. p38MAPK signaling pathway in osteoarthritis: pathological and therapeutic aspects. J Inflamm Res. 2022;15:723\u201334.","journal-title":"J Inflamm Res"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-025-05804-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-025-05804-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-025-05804-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T06:02:27Z","timestamp":1746252147000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-025-05804-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,3]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5804"],"URL":"https:\/\/doi.org\/10.1186\/s13018-025-05804-1","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,3]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of The Second Affiliated Hospital of Shandong First Medical University approved the research. The animal experimental was performed in accordance with ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"441"}}